CN100364593C - Oral liquid for promoting eyesight and protecting eye - Google Patents
Oral liquid for promoting eyesight and protecting eye Download PDFInfo
- Publication number
- CN100364593C CN100364593C CNB2006100075893A CN200610007589A CN100364593C CN 100364593 C CN100364593 C CN 100364593C CN B2006100075893 A CNB2006100075893 A CN B2006100075893A CN 200610007589 A CN200610007589 A CN 200610007589A CN 100364593 C CN100364593 C CN 100364593C
- Authority
- CN
- China
- Prior art keywords
- parts
- oral liquid
- fructus
- concha
- eyesight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000004438 eyesight Effects 0.000 title claims abstract description 21
- 239000007788 liquid Substances 0.000 title claims abstract description 15
- 230000001737 promoting effect Effects 0.000 title description 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 210000000582 semen Anatomy 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 15
- 241000628997 Flos Species 0.000 claims description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 9
- 241000522254 Cassia Species 0.000 claims description 6
- 241001523579 Ostrea Species 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 11
- 208000030533 eye disease Diseases 0.000 abstract description 10
- 210000004185 liver Anatomy 0.000 abstract description 9
- 230000008901 benefit Effects 0.000 abstract description 7
- 238000005728 strengthening Methods 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000035876 healing Effects 0.000 abstract description 2
- 240000000249 Morus alba Species 0.000 abstract 2
- 235000008708 Morus alba Nutrition 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 241000737241 Cocos Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 4
- 230000004304 visual acuity Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000019353 potassium silicate Nutrition 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 201000009487 Amblyopia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010015943 Eye inflammation Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000010415 Low Vision Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000027407 head symptom Diseases 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000004303 low vision Effects 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to oral liquid for improving eyesight and protecting eyes, and the raw materials of the oral liquid comprise chrysanthemum flower, mulberry leaf, concha hallotidis, mulberry, pachyma cocos, radix ophiopogonis, Chinese yam, oyster, wolferry fruit, plantain seed, cassia seed and glossy privet fruit. The oral liquid has the effects of strengthening body resistance, detoxicating, dispersing blood clots, nourishing yin for lowering fire, nourishing liver to improve eyesight and efficiently preventing and treating various eye diseases. The present invention has the advantages of quick effect, good healing effect, no toxic or side effect and low price.
Description
Technical field
The present invention relates to a kind of oral liquid that improves eyesight and protecting eye, is that a kind of what not only can effectively prevent but also can treat multiple oculopathy is the Chinese patent medicine of raw material with the Chinese herbal medicine.Belong to the field of Chinese medicines.
Background technology
Eyes are vitals that human body obtains external information, and the health of eye is self-evident.China has blind person more than 500 ten thousand at present, low vision person more than 600 ten thousand, and various inflammation cause that the affected patient of eye eyesight accounts for about 16% of population.Current, treatment oculopathy Western medicine commonly used, these Western medicine not only cost an arm and a leg, and toxic and side effects is also higher, and the method that improves vision at present is except that with the lenses which correct, and also available operation is proofreaied and correct, but the former can not improve vision, and latter's success rate is low, have a big risk, the cost height.The Chinese patent medicine of utilization Chinese herbal treatment oculopathy and raising vision is less.
Summary of the invention
The purpose of this invention is to provide a kind of oral liquid that improves eyesight and protecting eye, main effect is for improving vision, and the effective multiple oculopathy of prophylactic treatment, the advantage that have instant effect, good effect, have no side effect, price is low.
Solution of the present invention is according to the rule of the traditional Chinese medical science to curing eye diseases, i.e. the body resistance strengthening and constitution consolidating, the kidney invigorating collateral dredging, eliminating toxic substances to remove stasis, nourishing YIN to lower pathogenic fire, nourishing the liver to improve visual acuity.Tcm theory is thought, though oculopathy is local patholoic change, it and whole people's body is undivided, and thinks " liver opening at eye ", and the QI and blood elite of whole body is annotated in order the normal visual performance of competence exertion on all must be by meridians.The present invention forms according to above-mentioned rule, can the kidney invigorating collateral dredging, and eliminating toxic substances to remove stasis again can the body resistance strengthening and constitution consolidating, nourishing YIN to lower pathogenic fire, nourishing the liver to improve visual acuity.Flos Chrysanthemi of the present invention, Folium Mori and Semen Plantaginis can loose wind heat clearing away, cooling blood for improving eyesight, promoting diuresis to remove toxic substance.Fructus Lycii, Concha Haliotidis and Semen Cassiae tonifying kidney and improving eyesight, nourishing kidney lung moistening, clearing away liver-fire, nourishing the liver to improve visual acuity.Radix Ophiopogonis the kidney invigorating nourishing the liver, nourishing the lung to arrest cough, promoting the production of body fluid to quench thirst, clearing heat and relieving fidgetness.Fructus Ligustri Lucidi and the spleen invigorating of Rhizoma Dioscoreae lung benefiting, invigorating the liver and kidney, strong waist knee joint.Concha Ostreae and Poria eliminating dampness and diuresis, astringing intestine to stop diarrhea arresting sweating, softening and eliminating sputum, tranquilizing mind, sharp spleen helmet.It is cold that Fructus Mori belongs to acid, GUIXIN, liver, kidney channel, and beneficial blood and heat extraction are the enrich blood medicine of tonifying YIN of removing heat from blood, the body resistance strengthening and constitution consolidating of the present invention, eliminating toxic substances to remove stasis, nourishing YIN to lower pathogenic fire, nourishing the liver to improve visual acuity is played the merit that improves eyesight and protecting eye altogether.
The present invention is that following raw materials by weight proportions is made:
105～135 parts of 105～135 parts of Concha Haliotidis of 105～135 parts of Folium Mori of Flos Chrysanthemi
20～40 parts of 20～40 parts of Radix Ophiopogonis of 45～75 parts of Poria of Fructus Mori
45～75 parts of 45～75 parts of Fructus Lycii of 20～40 portions of Concha Ostreaes of Rhizoma Dioscoreae
20～40 parts of 15～25 parts of Fructus Ligustri Lucidi of 15～25 parts of Semen Cassiaes of Semen Plantaginis.
The preferred weight proportioning of each crude drug of the present invention is:
115～125 parts of 115～125 parts of Concha Haliotidis of 115～125 parts of Folium Mori of Flos Chrysanthemi
25～35 parts of 25～35 parts of Radix Ophiopogonis of 55～65 parts of Poria of Fructus Mori
55～65 parts of 55～65 parts of Fructus Lycii of 25～35 portions of Concha Ostreaes of Rhizoma Dioscoreae
25～35 parts of 17～22 parts of Fructus Ligustri Lucidi of 17～22 parts of Semen Cassiaes of Semen Plantaginis.
The optimum weight proportioning of each crude drug of the present invention is:
120 parts of 120 parts of Concha Haliotidis of 120 parts of Folium Mori of Flos Chrysanthemi
30 parts of 30 parts of Radix Ophiopogonis of 60 parts of Poria of Fructus Mori
60 parts of 60 parts of Fructus Lycii of 30 portions of Concha Ostreaes of Rhizoma Dioscoreae
30 parts of 20 parts of Fructus Ligustri Lucidi of 20 parts of Semen Cassiaes of Semen Plantaginis.
The oral liquid glass bottle of the raising eyesight and protecting eye that the present invention makes, every bottle of 10ml, oral, a 10～20ml, a twice-daily.10 days is a course of treatment, and be produce effects a common course of treatment.
Clinical drug of the present invention uses the result to show that following advantage is arranged;
1, the Chinese herbal medicine each component selected for use of the present invention meets the pharmaceutical control law regulation, utilizes the comprehensive function of the Chinese medicine of respectively distinguishing the flavor of to treat multiple oculopathy and improve vision.Show that through animal acute toxicity test underproof animal end sees any toxic reaction, its main organs does not have tangible change yet, and mice is 88g crude drug/kg to the maximum tolerated dose of medicinal liquid of the present invention, is 93.2 times of clinical people's consumption, and safety of medicine is reliable.
2, the present invention need not decoct, and mouthfeel is good, rich in proteins in the medicine, glucose, glucuronic acid, volatile oil, pectin, fructose, organic acid, lecithin, vitamin, aminoacid, also contain various trace elements such as Saponin, plant sterol and calcium, be beneficial to absorption of human body, health invigorating, and taking convenience.
3, the present invention can treat multiple oculopathy effectively and improve vision, has improved patient's life quality greatly, and higher healing rehabilitation efficacy is arranged.And the medical material cost is low, and is simple and practical.
For showing medicine of the present invention, as follows through clinical test results to treating the therapeutic effect of multiple oculopathy and raising vision; Treat eye inflammation (acute conjunctivitis) patient 30 examples that various inflammation cause, the age is 26～86 years old, and radical cure recovery from illness accounts for 48%, and produce effects accounts for 27%, effectively accounts for 19%, and is invalid 6%, and effective percentage reaches more than 94%.After a course of therapy, the patient all changes in conjunctival congestion, furious swollen, the head symptoms such as distending pain, and patient do not have any untoward reaction, and three big routine tests and hepatic and renal function detection are no abnormal.Treatment myopia, amblyopia patient's 50 examples, the age is 16～66 years old, and the radical cure recovery from illness accounts for 18%, and produce effects accounts for 29%, effectively accounts for 19%, and is invalid 36%, and effective percentage reaches more than 66%.And cost is low, and mouthfeel is good, instant effect and taking conveniently.
The specific embodiment
Take by weighing raw material by following weight: Flos Chrysanthemi 120g, Folium Mori 120g, Concha Haliotidis 120g, Fructus Mori 60g, Poria 30g, Radix Ophiopogonis 30g, Rhizoma Dioscoreae 30g, Concha Ostreae 60g, Fructus Lycii 60g, Semen Plantaginis 20g, Semen Cassiae 20g and Fructus Ligustri Lucidi 30g.
Production method is as follows: get Concha Haliotidis 120g, Poria 30g, Radix Ophiopogonis 30g, Rhizoma Dioscoreae 30g, Concha Ostreae 60g, Fructus Lycii 60g, Semen Plantaginis 20g, Semen Cassiae 20g and Fructus Ligustri Lucidi 30g earlier and clean roguing, dry, be ground into granule, again Flos Chrysanthemi 120g, Folium Mori 120g, Fructus Mori 60g are cleaned roguing, dry, pulverize, the raw material mixing and water adding of twice pulverizing was soaked 1 hour, put and decoct with water secondary in the multi-function extractor, add up for the first time the water of 10 times of amounts of medical material, decocted 1.5～2 hours, and got decocting liquid, filter.Add up for the second time the water of 7 times of amounts of medical material, decocted 1～1.2 hour, get twice decocting liquid and merge, filter, filtrate is inserted in the economic benefits and social benefits vacuum concentrator, and relative density is 1.05 concentrated solution when being concentrated into 90 ℃, puts 0～5 ℃ of deepfreeze 24 hours.Cold preservation liquid is added 0.3% filter aid kieselguhr, filter, filtrate is inserted in the economic benefits and social benefits vacuum concentrator again, is concentrated into every 1ml and contains 1g crude drug amount.Add the potassium sorbate that accounts for concentrated solution 0.2% again, add water to 1000ml again, stir, put 0～5 ℃ of deepfreeze 24 hours, cold preservation liquid is filtered, in the embedding bottle, 105 ℃ of high temperature sterilizes, packing is promptly.The oral liquid glass bottle of the raising eyesight and protecting eye that the present invention makes, every bottle of 10ml, oral, a 10～20ml, a twice-daily.
Claims (3)
1. oral liquid that improves eyesight and protecting eye is characterized in that it is made by following raw materials by weight proportions:
105～135 parts of 105～135 parts of Concha Haliotidis of 105～135 parts of Folium Mori of Flos Chrysanthemi
20～40 parts of 20～40 parts of Radix Ophiopogonis of 45～75 parts of Poria of Fructus Mori
45～75 parts of 45～75 parts of Fructus Lycii of 20～40 portions of Concha Ostreaes of Rhizoma Dioscoreae
20～40 parts of 15～25 parts of Fructus Ligustri Lucidi of 15～25 parts of Semen Cassiaes of Semen Plantaginis.
2. a kind of oral liquid that improves eyesight and protecting eye according to claim 1, wherein the weight proportion of each crude drug is:
115～125 parts of 115～125 parts of Concha Haliotidis of 115～125 parts of Folium Mori of Flos Chrysanthemi
25～35 parts of 25～35 parts of Radix Ophiopogonis of 55～65 parts of Poria of Fructus Mori
55～65 parts of 55～65 parts of Fructus Lycii of 25～35 portions of Concha Ostreaes of Rhizoma Dioscoreae
25～35 parts of 17～22 parts of Fructus Ligustri Lucidi of 17～22 parts of Semen Cassiaes of Semen Plantaginis.
3. a kind of oral liquid that improves eyesight and protecting eye according to claim 1, wherein the weight proportion of each crude drug is:
120 parts of 120 parts of Concha Haliotidis of 120 parts of Folium Mori of Flos Chrysanthemi
30 parts of 30 parts of Radix Ophiopogonis of 60 parts of Poria of Fructus Mori
60 parts of 60 parts of Fructus Lycii of 30 portions of Concha Ostreaes of Rhizoma Dioscoreae
30 parts of 20 parts of Fructus Ligustri Lucidi of 20 parts of Semen Cassiaes of Semen Plantaginis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100075893A CN100364593C (en) | 2006-02-20 | 2006-02-20 | Oral liquid for promoting eyesight and protecting eye |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100075893A CN100364593C (en) | 2006-02-20 | 2006-02-20 | Oral liquid for promoting eyesight and protecting eye |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1843457A CN1843457A (en) | 2006-10-11 |
| CN100364593C true CN100364593C (en) | 2008-01-30 |
Family
ID=37062443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100075893A Expired - Fee Related CN100364593C (en) | 2006-02-20 | 2006-02-20 | Oral liquid for promoting eyesight and protecting eye |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100364593C (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101700317B (en) * | 2009-11-16 | 2012-02-01 | 武汉代代木生物科技有限公司 | Preparation capable of improving fundus and retina microcirculation lesion and restoring ocular and retina microcirculation lesion and damage, and method for preparing same |
| CN103816286B (en) * | 2013-11-08 | 2018-03-16 | 大兴安岭冰莓庄园生物科技发展有限公司 | For alleviating the blueberry compound oral liquid prescription and its preparation technology of asthenopia |
| CN104083583A (en) * | 2014-07-31 | 2014-10-08 | 秦增琳 | Traditional Chinese medicine liquid for improving eyesight and preparation method thereof |
| CN104547534B (en) * | 2015-02-03 | 2018-08-24 | 青岛市妇女儿童医院 | A kind of herbal health care oral solution with efficacy of relieving visual fatigue |
| CN105796850A (en) * | 2016-03-17 | 2016-07-27 | 陆开云 | Traditional Chinese medicine eye caring plaster |
| CN108671077A (en) * | 2018-07-31 | 2018-10-19 | 殷军如 | It is a kind of to treat the low Chinese medicine and preparation method thereof of eye eyesight |
| CN113796535A (en) * | 2021-09-16 | 2021-12-17 | 天津儒益康中医药科技有限公司 | A health product prepared from fructus Lycii, flos Chrysanthemi, and rhizoma Dioscoreae, and its preparation method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1077595A (en) * | 1993-02-02 | 1993-10-27 | 浏阳县茶叶公司 | A kind of health protection tea |
| CN1480055A (en) * | 2002-09-06 | 2004-03-10 | 伟 孙 | Nuntritioin enhanced health tea for computer users and preparation method |
-
2006
- 2006-02-20 CN CNB2006100075893A patent/CN100364593C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1077595A (en) * | 1993-02-02 | 1993-10-27 | 浏阳县茶叶公司 | A kind of health protection tea |
| CN1480055A (en) * | 2002-09-06 | 2004-03-10 | 伟 孙 | Nuntritioin enhanced health tea for computer users and preparation method |
Non-Patent Citations (2)
| Title |
|---|
| 眼科常用中药杂记. 谷万章.航空航天医药，第15卷第3期. 2004 * |
| 菊花在眼科的临床应用. 沈丽珍.中国中医眼科杂志，第11卷第2期. 2001 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1843457A (en) | 2006-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101559195B (en) | Epilepsy therapy capsule and preparation method thereof | |
| CN103393969A (en) | Eye drop used for releasing eye fatigue and preparation method thereof | |
| CN109528500A (en) | A kind of eye sticker composition and preparation method thereof | |
| CN101954028A (en) | Medicinal pillow for preventing and treating myopic eyes | |
| CN106236875A (en) | A kind of Chinese medicine composition of liver heat removing and eyesight improving and preparation method thereof | |
| CN100364593C (en) | Oral liquid for promoting eyesight and protecting eye | |
| CN104758690A (en) | Traditional Chinese medicinal preparation for treating pre-operative anesthesia and preparation method of traditional Chinese medicinal preparation | |
| CN104922299A (en) | Traditional Chinese medicine healthcare oral liquid used for preventing and treating diabetic retinopathy | |
| CN106334107A (en) | Traditional Chinese medicine eye drops and preparation method thereof | |
| CN104623232A (en) | Traditional Chinese medicine composition for treating tinnitus | |
| CN101112501A (en) | Chinese traditional medicine composition for treating diabetic hypertension | |
| CN101112538A (en) | Chinese traditional medicine preparations for treating diabetic hypertension | |
| CN103520649B (en) | The Chinese medicine for the treatment of facial neuritis | |
| CN104645078A (en) | Traditional Chinese medicine composition for treating migraine | |
| CN104606561A (en) | Traditional Chinese medicinal composition for treating spontaneous perspiration | |
| CN109700889A (en) | A kind of Chinese medicine composition and preparation method thereof of health care eyes | |
| CN102380041B (en) | Traditional Chinese herbal lotion preparation method for curing night sweat decubitus | |
| CN103948870A (en) | Traditional Chinese medicine preparation for treating nerve headache | |
| CN104258295A (en) | Traditional Chinese medicine decoction for treating lymphoma | |
| CN115089633B (en) | Composition for preventing and treating myopia, eye mask and preparation method | |
| CN105194279A (en) | Drug for treating dry eye syndrome | |
| CN104645052A (en) | Preparation method of external medicine for nerve injury | |
| CN104784588A (en) | Traditional Chinese medicine preparation for treating nerve headache and preparation method | |
| CN117752637A (en) | Plaster and preparation method thereof | |
| CN104491403A (en) | Medicine for treating central retinochoroiditis and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080130 Termination date: 20110220 |